comparemela.com

Latest Breaking News On - சையத் காஜ்மி - Page 3 : comparemela.com

New RMIT tech develops sustainable concrete from tyre and construction waste

Architecture news & editorial desk From used coffee cups to building rubble and everything in between, recycled waste has been utilised to create concrete products that promise several environmental benefits. While recycled concrete aggregates contribute to reducing landfill and CO2 emissions, save natural resources and boost the circular economy, challenges still remain in matching the strength and durability of traditional concrete, hindering their practical application. The concept of ‘sustainable concrete’ just got a major boost with RMIT researchers developing a new technology to produce stronger, more durable and sustainable concrete products from a mix of rubber tyres and construction and demolition waste. Prefabricated concrete products cast using the new technology are up to 35% stronger than traditional concrete.

Jubilant Therapeutics Announces Research Collaboration with The Wistar Institute to Evaluate the Activity of Novel PAD4 Inhibitors to Reduce Clinical Severity of COVID-19

(1) BEDMINSTER, N.J., Jan. 15, 2021 /PRNewswire/ Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced a collaboration with The Wistar Institute, an international leader in biomedical research, to evaluate the ability of Peptidyl Arginine Deiminase 4 (PAD4) inhibitors provided by Jubilant Therapeutics to block neutrophil extracellular trap (NET) formation in the context of COVID-19 related cytokine storms. PAD4 is an enzyme that catalyzes conversion of arginine to citrulline in proteins, including histones and is highly expressed in neutrophils. Histone citrullination has been implicated in Neutrophil Extracellular Trap (NET) formation and accumulating evidence suggests that NETs may be linked to the severity of COVID-19, as their formation is a result of pro-inflammatory cytokine release syndrome (CRS), or cytokine storms, produced by the body s immune resp

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.